Starting today, the AllTrials campaign is publicising one clinical trial that hasn’t reported results every week in the BMJ.
This unreported trial of the week will be one that the recently launched FDAAA TrialsTracker shows is overdue reporting results and that was nominated by one of the hundreds of patient groups and thousands of people who are part of the AllTrials campaign. The trial could be on any treatment and any disease area, it just has to be registered on the world’s largest register ClinicalTrials.gov and subject to the US’s FDAAA law.
We are publicising unreported clinical trials to get the results reported. We know this works. In February 2018 the team at the EBMDataLab which developed the tracker highlighted one unreported trial on their blog and 7 days later the research team responsible at Columbia University reported the results!
The FDAAA Compliance Tracker is aimed at trying to stop new clinical trials from going overdue. In the meantime, AllTrials is working to get missing results from old trials published – the results we need to make good decisions about today’s and tomorrow’s medicines. If you can help us with that, please consider donating to AllTrials.
Introducing unreported clinical trial of the week, the BMJ (29 March 2018)
Read about all the trials we’ve highlighted so far.